Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-DOPA for Fear Extinction in PTSD
NCT02560389Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Mar 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa in post-traumatic stress disorder (PTSD), sponsored by University of Wisconsin–Madison. Started Mar 2016; status: completed.
02
Drugs
levodopa
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02560389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02560389.